**7. References**


[9] Piffanelli A, Dafermou A, Giganti M, et al. Radionulide therapy for painful bone

[10] Wang Rongfu. Prospect of clinical application of radionuclide therapy in skeletal and

[11] Wang Rongfu. Prospect of clinical application of radionuclide imaging in skeletal and

[12] Savelli G, Maffioli L, Maccauro M, et al. Bone scintigraphy and the add value of SPECT

[13] Cook GJ, Fogelman I. The role of positron emission tomography in management of

[14] Evan-Sapir E, Mester U, Flusser G, et al. Assessment of malignant skeletal disease:

[15] Zhang H, Tian M, Oriuchi N, et al. 11C-choline PET for the detection of bone and soft

[16] Brenner W, Bohuslavizki KH, Eary JF. PET imaging of osteosarcoma. J Nucl Med, 2003,

[17] Wang Rong-fu. Application study and development of molecular nuclear medicine. J

[18] Wang Rong-fu. New technique Application of PET/CT. CT Theory & Application, 18(4):

[19] Wang RF. Clinical and positron imaging with coincidence detection. Beijing: Peking

[20] Wang RF. Progress in imaging agents of cell apoptosis. Anti-Cancer Agents in Medical

[21] Ali Sarikaya, Saniye Sen, Sevim Hacimahmutoglu, etc. 99mTc(V)-DMSA scintigraphy in

[22] Shahram Dabiri. 99mTc(V)-DMSA in Detection of Metastases of Medullary Thyroid

[23] Charito Love, Christopher J. Palestro. Radionuclide imaging of infection J Nucl Med

[24] Wang Rong-fu. Diagnostics of PET/CT in Oncology. Beijing, Peking Univ Med Press,

[25] Ali Agool, Andor W.J.M. Glaudemans, Hendrikus H. Boersma, etal. Radionuclide

[26] Sousa Ricardoa, Massada Martaa, Pereira Alexandrea, etal. Diagnostic accuracy of

[27] Ryo Takagi, Yuji Suzuki, Yoshiko Seki,etal. Indium chloride-induced micronulei in in vivo and invtro experimental systems. J Occupational Health, 2011, 53(2): 102-109. [28] Lou Lawrencea, Alibhai Karim N.b, Winkelaar Gerrit B.b, etal. 99mTc-WBC

[29] Zhao Yuan, Wang Rongfu, Liu Pengcheng. Current status and recent advance in 125I seed implantation in the treatment for malignant tumors. J Oncol, 2010, 16(6): 432-431.

imaging of bone marrow disorders. Eur J Nucl Med Mol Imaging, 2011, 38(1):166-178.

combined 99mTc-sulesomab and 99mTc-nanocolloid bone marrow imaging in detecting prosthetic joint infection. Nuclear Medicine Communications, 2011, 32(9):

scintigraphy with SPECT/CT in the evaluation of arteral graft infection. Nuclear

osteodystrophy. Annals of Nuclear Medicine, 2002, 16(1): 19–23.

monitoring the response of bone disease to vitamin D3 therapy in renal

initial experience with 18F-fluoride PET/CT and comparison between 18F-fluoride

tissue tumors in comparison with FDG PET. Nucl Med Commun, 2003, 24(3): 273-

metastases. Q J Nucl Med, 2001, 45(1): 100-107.

soft tissue tumors(Part I). Chi Med News, 2006, 21(4): 13.

soft tissue tumors(Part II). Chi Med News, 2006, 21(2): 15.

bone metastases. Cancer, 2000, 88(12 Suppl): 2927-2933.

chin Clin Med Imaging, 2008,19(8): 585-590.

Carcinoma. Iran J Nucl Med 2006; 14(26): 15-24.

Medicine Communications, 2010, 31(5): 411-416.

279.

9-14.

2008

834-839.

44(6): 930-942.

Univ Med Press, 2004.

Chemistry, 2009, 9(9): 996-1002.

Technol, 2004, 32(2): 47-57.

in detecting skeletal lesions. Q J Nucl Med, 2001, 45(1): 27-37.

PET and 18F-fluoride PET/CT. J Nucl Med, 2004, 45(2): 272-278.
